Ditechnetium heptoxide was synthesized from the oxidation of TcO with O at 450 °C and characterized by single-crystal X-ray diffraction, electron-impact mass spectrometry (EI-MS), and theoretical methods. Refinement of the structure at 100 K indicates that TcO crystallizes as a molecular solid in the orthorhombic space group Pbca [a = 7.312(3) Å, b = 5.562(2) Å, c = 13.707(5) Å, and V = 557.5(3) Å]. The TcO molecule can be described as corner-sharing TcO tetrahedron [Tc---Tc = 3.698(1) Å and Tc-O-Tc = 180.0°]. The EI-MS spectrum of TcO consists of both mononuclear and dinuclear species. The main dinuclear species in the gas-phase are TcO (100%) and TcO (56%), while the main mononuclear species are TcO (33.9%) and TcO (42.8%). The difference in the relative intensities of the MO (M = Tc, Re) fragments (1.7% for Re) indicates that these group 7 elements exhibit different gas-phase chemistry. The solid-state structure of TcO was investigated by density functional theory methods. The optimized structure of the TcO molecule is in good agreement with the experimental one. Simulations indicate that the more favorable geometry for the TcO molecule in the gas-phase is bent (Tc-O-Tc = 156.5°), while a linear geometry (Tc-O-Tc = 180.0°) is favored in the solid-state.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.inorgchem.6b01683DOI Listing

Publication Analysis

Top Keywords

tco
12
tco molecule
12
ditechnetium heptoxide
8
dinuclear species
8
structure tco
8
heptoxide revisited
4
revisited solid-state
4
gas-phase
4
solid-state gas-phase
4
gas-phase theoretical
4

Similar Publications

Pretargeted Multimodal Tumor Imaging by Enzymatic Self-Immobilization Labeling and Bioorthogonal Reaction.

J Am Chem Soc

January 2025

State Key Laboratory of Analytical Chemistry for Life Science, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Road, Nanjing 210023, China.

Covalent modification of cell membranes has shown promise for tumor imaging and therapy. However, existing membrane labeling techniques face challenges such as slow kinetics and poor selectivity for cancer cells, leading to off-target effects and suboptimal efficacy. Here, we present an enzyme-triggered self-immobilization labeling strategy, termed E-SIM, which enables rapid and selective labeling of tumor cell membranes with bioorthogonal trans-cycloctene (TCO) handles .

View Article and Find Full Text PDF

Bioorthogonal strategy-triggered In situ co-activation of aggregation-induced emission photosensitizers and chemotherapeutic prodrugs for boosting synergistic chemo-photodynamic-immunotherapy.

Biomaterials

January 2025

State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, PR China. Electronic address:

In situ activation of prodrugs or photosensitizers is a promising strategy for specifically killing tumor cells while avoiding toxic side effects. Herein, we originally develop a bioorthogonally activatable prodrug and pro-photosensitizer system to synchronously yield an aggregation-induced emission (AIE) photosensitizer and a chemotherapeutic drug for synergistic chemo-photodynamic-immunotherapy of tumors. By employing molecular engineering strategy, we rationally design a family of tetrazine-functionalized tetraphenylene-based photosensitizers, one of which (named TzPS5) exhibits a high turn-on ratio, a NIR emission, a typical AIE character, and an excellent ROS generation efficiency upon bioorthogonal-activation.

View Article and Find Full Text PDF

Bioorthogonal chemistry, recognized as a highly efficient tool in chemical biology, has shown significant value in cancer treatment. The primary objective is to develop efficient delivery strategies to achieve enhanced bioorthogonal drug treatment for tumors. Here, Janus microparticles (JMs) loaded with cyclooctene-modified doxorubicin prodrug (TCO-DOX) and tetrazine-modified indocyanine green (Tz-ICG) triggers are reported.

View Article and Find Full Text PDF

Phylogenetic characterization of Bifidobacterium kimbladii sp. nov., a novel species from the honey stomach of the honeybee Apis mellifera.

Syst Appl Microbiol

January 2025

Department of Laboratory Medicine, Medical Microbiology, Lund University, Medicon Village, SE-223 81 Lund, Sweden.; ConCellae AB, Bårslövsvägen 3, 25373 Helsingborg, Sweden.

Six novel Bifidobacterium strains H1HS16N, Bin2N, Hma3N, H6bp22N, H1HS10N, and H6bp9N, were isolated from the honey stomach of Apis mellifera. Cells are Gram-positive, non-motile, non-sporulating, facultatively anaerobic, and fructose 6-phosphate phosphoketolase-positive. Optimal growth conditions occur at 37 °C in anaerobiosis in MRS medium added with 2 % fructose and 0.

View Article and Find Full Text PDF

In situ labeling of pretargeted hyaluronan for PET/MR imaging of CD44+ tumors.

Bioorg Chem

December 2024

School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, PR China; College of Pharmacy, Dali University, Xia Guan, Dali, Yunnan 6710000, PR China. Electronic address:

Background: Tumor-specific molecular probe-based imaging strategies have shown great potential for tumor diagnosis. However, the sensitivity and contrast of imaging may interfere with the complex labeling process and degradation of tumor-specific imaging probes. We sought to adapt a pretargeting strategy and an in vivo bioorthogonal reaction to improve hyaluronan (HA)-based tumor multimodal imaging diagnosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!